Search Results - "Justin P Rubio"

Refine Results
  1. 1
  2. 2

    Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination by Chen, Yongfeng, Zhen, Wei, Guo, Tony, Zhao, Yonggang, Liu, Ailian, Rubio, Justin P, Krull, David, Richardson, Jill C, Lu, Hongtao, Wang, Ryan

    Published in PloS one (18-12-2017)
    “…Agents promoting oligodendrocyte precursor cell differentiation have the potential to restore halted and/or delayed remyelination in patients with multiple…”
    Get full text
    Journal Article
  3. 3

    SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive by Libert, Sergiy, Pointer, Kelli, Bell, Eric L., Das, Abhirup, Cohen, Dena E., Asara, John M., Kapur, Karen, Bergmann, Sven, Preisig, Martin, Otowa, Takeshi, Kendler, Kenneth S., Chen, Xiangning, Hettema, John M., van den Oord, Edwin J., Rubio, Justin P., Guarente, Leonard

    Published in Cell (23-12-2011)
    “…SIRT1 is a NAD +-dependent deacetylase that governs a number of genetic programs to cope with changes in the nutritional status of cells and organisms…”
    Get full text
    Journal Article
  4. 4

    Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells by Wilson, Paul A, Santos Franco, Sara, He, Liu, Galwey, Nicholas W, Meakin, Jackie, McIntyre, Rebecca, McHugh, Simon M, Nolan, Michael A, Spain, Sarah L, Carlson, Thaddeus, Lobera, Mercedes, Rubio, Justin P, Davis, Bill, McCarthy, Linda C

    Published in PloS one (21-10-2021)
    “…RORγt is an isoform of RORC, preferentially expressed in Th17 cells, that functions as a critical regulator of type 3 immunity. As murine Th17-driven…”
    Get full text
    Journal Article
  5. 5

    Splicing, cis genetic variation and disease by Jensen, Cathy J, Oldfield, Brian J, Rubio, Justin P

    Published in Biochemical Society transactions (01-12-2009)
    “…Splicing is a post-transcriptional modification of RNA during which introns are removed and exons are joined. Most of the mammalian genes undergo constitutive…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Opioid Switch Dosing in Chronic Cancer Pain: A Prospective Longitudinal Study by Wong, Aaron K, Klepstad, Pal, Rubio, Justin P, Somogyi, Andrew A, Vogrin, Sara, Le, Brian, Philip, Jennifer

    Published in Journal of palliative medicine (01-03-2024)
    “…Opioid switching is common, however, conversion tables have limitations. Guidelines suggest postswitch dose reduction, yet, observations show opioid doses may…”
    Get more information
    Journal Article
  10. 10

    Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci by Patsopoulos, Nikolaos A., de Bakker, Paul I. W.

    Published in Annals of neurology (01-12-2011)
    “…Objective: To perform a 1‐stage meta‐analysis of genome‐wide association studies (GWAS) of multiple sclerosis (MS) susceptibility and to explore functional…”
    Get full text
    Journal Article
  11. 11

    Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females by Loesch, Danuta Z., Tassone, Flora, Mellick, George D., Horne, Malcolm, Rubio, Justin P., Bui, Minh Q., Francis, David, Storey, Elsdon

    Published in Movement disorders (01-07-2018)
    “…ABSTRACT Background and Objective There is convincing evidence that small CGG expansion (41‐54 repeats): FMR1 “gray zone” alleles (GZ) contribute to the risk…”
    Get full text
    Journal Article
  12. 12

    Variants of ST8SIA1 are associated with risk of developing multiple sclerosis by Husain, Seema, Yildirim-Toruner, Cagri, Rubio, Justin P, Field, Judith, Schwalb, Marvin, Cook, Stuart, Devoto, Marcella, Vitale, Emilia

    Published in PloS one (09-07-2008)
    “…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown etiology with both genetic and environmental factors…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping by Beck, Hans-Peter, Wampfler, Rahel, Carter, Nick, Koh, Gavin, Osorio, Lyda, Rueangweerayut, Ronnatrai, Krudsood, Srivcha, Lacerda, Marcus V., Llanos-Cuentas, Alejandro, Duparc, Stephan, Rubio, Justin P., Green, Justin A.

    Published in The Journal of infectious diseases (01-03-2016)
    “…Prevention of relapse of Plasmodium vivax infection is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized,…”
    Get full text
    Journal Article
  15. 15

    Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan by Koshy, Beena, Miyashita, Akinori, St Jean, Pamela, Stirnadel, Heide, Kaise, Toshihiko, Rubio, Justin P, Mooser, Vincent, Kuwano, Ryozo, Irizarry, Michael C

    Published in Journal of Alzheimer's disease (02-09-2010)
    “…High plasma lipoprotein phospholipase A2 activity (Lp-PLA2) is reported to be a risk factor for dementia. A loss of function polymorphism in the Lp-PLA2 gene -…”
    Get more information
    Journal Article
  16. 16

    Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells by Paul A Wilson, Sara Santos Franco, Liu He, Nicholas W Galwey, Jackie Meakin, Rebecca McIntyre, Simon M McHugh, Michael A Nolan, Sarah L Spain, Thaddeus Carlson, Mercedes Lobera, Justin P Rubio, Bill Davis, Linda C McCarthy

    Published in PloS one (21-10-2021)
    “…RORγt is an isoform of RORC, preferentially expressed in Th17 cells, that functions as a critical regulator of type 3 immunity. As murine Th17-driven…”
    Get full text
    Journal Article
  17. 17

    Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics by Chen, Shuguang, St Jean, Pamela, Borland, Julie, Song, Ivy, Yeo, Astrid J, Piscitelli, Stephen, Rubio, Justin P

    Published in Pharmacogenomics (01-01-2014)
    “…To evaluate potential pharmacogenetic effects of UGT1A1 polymorphisms on the pharmacokinetics (PK) of dolutegravir (Tivicay®; ViiV Healthcare, NC, USA), an…”
    Get more information
    Journal Article
  18. 18

    Exome array analysis suggests an increased variant burden in families with schizophrenia by McCarthy, Nina S, Melton, Phillip E, Ward, Sarah V, Allan, Spencer M, Dragovic, Milan, Clark, Melanie L, Morar, Bharti, Rubio, Justin P, Blangero, John, Badcock, Johanna C, Morgan, Vera A, Moses, Eric K, Jablensky, Assen

    Published in Schizophrenia research (01-07-2017)
    “…Abstract The exome array assays rare-but-recurrent, likely deleterious, exonic variants and represents an intermediary between single nucleotide polymorphism…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies by BAHLO, Melanie, STANKOVICH, Jim, DANOY, Patrick, HICKEY, Peter F, TAYLOR, Bruce V, BROWNING, Sharon R, BROWN, Matthew A, RUBIO, Justin P

    “…As of June 2009, 361 genome-wide association studies (GWAS) had been referenced by the HuGE database. GWAS require DNA from many thousands of individuals,…”
    Get full text
    Journal Article